One of the top goals of mesothelioma researchers is to find a way to diagnose malignant mesothelioma earlier. The rare and fatal form of cancer typically does not get diagnosed until it is in its latest stages, and that makes effective treatment virtually impossible. While scientists have spent countless hours trying to devise more accurate
Between malignant pleural mesothelioma and malignant peritoneal mesothelioma — the two most frequently-made mesothelioma diagnoses — peritoneal mesothelioma occurs far less frequently. Among the roughly 3,500 patients diagnosed with the deadly form of asbestos-related cancer in the United States each year, only about 700 have the tumors appear in their abdominal lining: almost all others
Interferon Alfa-2b clinical trials are recruiting mesothelioma patients to test this new gene therapy. Researchers insert manipulated genetic material into the cancer cells to convert them into cancer-killing cells. Similar gene therapy has been used in other types of cancer patients, and now those with pleural mesothelioma may be able to benefit from it. What
Ricardo Rimondi is one among many mesothelioma victims who are seeking compensation from Johnson & Johnson: he holds the company responsible because he believes they knew their popular baby powder was contaminated with asbestos and did nothing about it. This week a New Jersey jury listened to testimony from his family, speaking of the challenges
Immunotoxin clinical trials are testing a type of immunotherapy in mesothelioma patients. It uses immune-modulating drugs to selectively target and kill cancer cells. The trials with mesothelioma patients show promise and may include combinations with other treatments. What Is an Immunotoxin? Immunotoxins are targeted compounds that use designed molecules to attach to cancer cells. As
Thoracic surgeons are on the front lines of the battle against malignant pleural mesothelioma. These physicians not only work to help specific patients, but also report back to their colleagues about their findings in a constant effort to advance their understanding of the disease. They share what works and what doesn’t so that every mesothelioma
Mesothelioma commercial scripts are designed to bring awareness to anyone who might have been exposed to asbestos and is at risk for mesothelioma. While some messages may seem misleading, most are paid for by actual mesothelioma law firms who genuinely want to help victims of asbestos exposure. Before you make a move, let us help
Anetumab ravtansine clinical trials are currently testing the effectiveness and the safety of this experimental cancer and mesothelioma drug made by Bayer. Anetumab revtansine selectively targets certain types of cancer cells to deliver a cytotoxic drug directly to them, minimizing harm to healthy cells. These trials provide later-stage patients with another option for treatment. What
Every year, people with rare disorders and their families, friends and communities mark Rare Disease Day, an initiative launched by the National Organization for Rare Disorders (NORD). In 2019, the day will be marked on February 28 with events, awareness programs and activities across the country. There are over 7,000 rare diseases that affect 25
Though all physicians treating patients with mesothelioma have the same goal of providing their patients with the best possible outcome and longest possible survival, there are disagreements about how that should be achieved. Most agree that patients do best with a combination of surgery and other modalities such as chemotherapy and radiation therapy, but where